imatinib mesylate has been researched along with Primary Peritonitis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cochet, H; Hennig, A; Leger, A; Peyrou, J | 1 |
Ha, HK; Kim, AY; Kim, HJ; Kim, JS; Lee, JS; Park, SH | 1 |
Hur, H; Jee, SB; Jeon, HM; Jung, SE; Kim, W; Park, AR | 1 |
Kovacsovics, T; Meylan, P; Senn, L; Tarr, PE | 1 |
4 other study(ies) available for imatinib mesylate and Primary Peritonitis
Article | Year |
---|---|
Endomyocardial fibrosis in a context of peritonitis.
Topics: Abdominal Pain; Adrenal Cortex Hormones; Cardiomyopathy, Restrictive; Drug Therapy, Combination; Emergency Service, Hospital; Endomyocardial Fibrosis; Epstein-Barr Virus Infections; Follow-Up Studies; Furosemide; Humans; Image Enhancement; Imatinib Mesylate; Lymphoma; Magnetic Resonance Imaging, Cine; Male; Peritonitis; Thrombolytic Therapy; Tomography, X-Ray Computed; Young Adult | 2017 |
Computed tomography features and predictive findings of ruptured gastrointestinal stromal tumours.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Ascites; Disease Progression; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hematoma; Hemoperitoneum; Humans; Imatinib Mesylate; Indoles; Intestine, Small; Male; Middle Aged; Necrosis; Peritonitis; Pyrroles; Rupture, Spontaneous; Sensitivity and Specificity; Sunitinib; Tomography, X-Ray Computed; Young Adult | 2017 |
Perforation of the colon by invading recurrent gastrointestinal stromal tumors during sunitinib treatment.
Topics: Aged; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Perforation; Male; Neoplasm Recurrence, Local; Peritonitis; Piperazines; Pyrimidines; Pyrroles; Sunitinib | 2008 |
Peritoneal tuberculosis after imatinib therapy.
Topics: Adult; Antineoplastic Agents; Antitubercular Agents; Benzamides; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphopenia; Male; Opportunistic Infections; Peritonitis; Peritonitis, Tuberculous; Piperazines; Pyrimidines | 2009 |